Exercise of ESOP Options
Jubilant Life Sciences Ltd has informed BSE that 3,604 options under Jubilant Employees Stock Option Plan 2005 (Plan 2005) and 5,194 options under JLL Employees Stock Option Plan 2011 (Plan 2011) have been exercised by the option holders.Pursuant to the terms of Plan 2005 and Plan 2011, the Nomination, Remuneration and Compensation Committee of the Company (the Committee") has approved on January 20, 2016, transfer of 23,214 equity shares... Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jubilant Stock Holding Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Jubilant Life Sciences Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Exercise of ESOP Options
Jubilant Life Sciences Ltd has informed BSE that 7,650 options under Jubilant Employees Stock Option Plan 2005 ("Plan 2005") and 49,344 options under JLL Employees Stock Option Plan 2011 ("Plan 2011") have been exercised by the option holders.Pursuant to the terms of Plan 2005 and Plan 2011, the Nomination, Remuneration and Compensation Committee of the Company (the "Committee") has approved, on December 18, 2015, transfer of 87,594 equity... Authorised KMPs to determine materiality of events/information
Jubilant Life Sciences Ltd has informed BSE has informed BSE regarding "Authorised Key Managerial Personnel to determine materiality of events/information". Jubilant Life Sciences hits lifetime high on getting approval for Paroxetine tablets
The stock moved higher by 10% to Rs 452 on the BSE. Jubilant Life Sciences receives ANDA approval for Paroxetine Tablets
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated December 01, 2015, titled "Jubilant Life Sciences receives ANDA approval for Paroxetine Tablets". Exercise of ESOP Stock Options
Jubilant Life Sciences Ltd has informed BSE that 5,560 options under Jubilant Employees Stock Option Plan 2005 (Plan 2005) and 1,76,906 options under JLL Employees Stock Option Plan 2011 (Plan 2011) have been exercised by the option holders.Pursuant to the terms of Plan 2005 and Plan 2011, the Nomination, Remuneration and Compensation Committee of the Company (the Committee) has approved, on November 09, 2015, transfer of 2,04,706 equity... Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jubilant Stock Holding Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE
Jubilant Life plans to raise $200 million
The firm will look to raise the funds by either raising equity or through other instruments such as foreign currency convertible bonds, global depository receipts etc